Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiation.

MLA

Hahn, Cynthia K., et al. “Expression-Based Screening Identifies the Combination of Histone Deacetylase Inhibitors and Retinoids for Neuroblastoma Differentiation.” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 28, July 2008, pp. 9751–56. EBSCOhost, https://doi.org/10.1073/pnas.0710413105.

APA

Hahn, C. K., Ross, K. N., Warrington, I. M., Mazitschek, R., Kanegai, C. M., Wright, R. D., Kung, A. L., Golub, T. R., & Stegmaier, K. (2008). Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiation. Proceedings of the National Academy of Sciences of the United States of America, 105(28), 9751–9756. https://doi.org/10.1073/pnas.0710413105

Chicago

Hahn, Cynthia K., Kenneth N. Ross, Ian M. Warrington, Ralph Mazitschek, Cindy M. Kanegai, Renee D. Wright, Andrew L. Kung, Todd R. Golub, and Kimberly Stegmaier. 2008. “Expression-Based Screening Identifies the Combination of Histone Deacetylase Inhibitors and Retinoids for Neuroblastoma Differentiation.” Proceedings of the National Academy of Sciences of the United States of America 105 (28): 9751–56. doi:10.1073/pnas.0710413105.